• Advanced Institute of Engineering and Technology (AVITECH)

  • Seminars

    January 10, 2023: Dr. Luu Phuc Loi (Pacific Informatics, Vietnam), Epigenomics in clinical applications

    More and more genetic and genomic testing are developed and approved to be used in clinic after human genome project finished in 2001. With the emerging of NGS in 2005, the genetic and genomic testing is further advanced and plays an important role in clinical diagnosis and prognosis. Were born later, epigenetic and epigenomic testing are still unmature and in development phase. However, there are a few tests available for several cancers in oncology hospitals. These tests are not only for pronosis and diagnosis but also for monitoring the treatments. In this presentation, Loi will share the journey of development clinical epigenetic (DNA methylation) markers including tissue and liquid biopsy in some cancers and infection disease. In addition, Loi will also show some data of pharmaco-epigenomics in treatment of breast cancer using epigenetics drugs.

    Speaker: Dr. Luu Phuc Loi, Pacific Informatics, Vietnam

    Time: 3:30-4:30pm, Tuesday, January 10, 2023

    Venue: Webinar; Access code: https://bit.ly/3QcEs21

    speaker

    Dr. Loi is a Bioinformatics Team Leader at Pacific Informatics, Vietnam. Dr. Loi has been working as a medical researcher at Garvan Institute of Medical Research, Sydney, Australia since 2014. He has developed a long-term interest in clinical epigenetics and genomics using the next-generation sequencing (NGS) technologies since his Bioinformatics Master training at the Max Planck Institute for Informatics and doctoral at the Max Planck Institute for Molecular Biomedicine, Germany during 2008 – 2014. Based on the NGS, Loi has built multiple bioinformatics tools and wet-let protocols for a wide range of studies from mechanism studies to translational research. After moving to Garvan, Loi established his own research topic on translational studies including pharmaco-epigenomics and epigenetics biomarker development for prognosis, diagnosis and disease progression monitoring in breast, prostate cancer, and rare genetic diseases. He has (co)-authored several publications in high impact factor journals such as Nature communications, Cancer cell, Clinical and Translational Medicine, Genome Research.

    SAME CATEGORY

    February 2, 2024: Dr. Khoa D. Doan (Vin Univeristy) Toward Reliable and Practical Machine Learning Applications

    While Machine Learning (ML) has rapidly transformed several domains and applications with incredible successes, there are also important areas where the progress is significantly slower. Specifically, there exists a widened complexity gap between the methods currently investigated in research and those used in practice in these areas. One reason is that many algorithms, despite achieving […]

    February 2, 2024: Prof. Heng Ji (University of Illinois at Urbana-Champaign), Combating with Misinformation and Cancer: A Unified Multimodal AI Approach to Healthy and Happy Life

    A research overview of ongoing research projects, especially focusing on two that are most related to the VinUni-UIUC Smart Health Center: (1) Misinformation Detection and Trustworthy Large Language Models; (2) Joint Natural Language and Molecule Learning for Drug Discovery. Unsurprisingly these two seemingly different research problems can be tackled with a unified approach based on […]

    January 11, 2024: Dr. Le Duc Trong (FIT-UET) Resilient Multimodal Learning for Multimodal Emotion Recognition in the Presence of Incomplete Modalities

    Multimodal Emotion Recognition in Conversation (Multimodal ERC) is a critical area of research for interpreting human communication in diverse applications. Nevertheless, the persistent issue of uncertain missing modalities poses a major hurdle, hampering the development of robust Multimodal ERC models. Existing approaches face limitations in effectively leveraging a fusion of diverse data modalities encompassing audio, […]